Biogen Inc.
BIIB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000875045
In the last 90 days, Biogen Inc. insiders filed 0 open-market purchases and 1 sale; 1,047 institutions reported holding it in 13F filings for Q2 2026, worth $30.7B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Biogen Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 955 | 13 | 947 | +5 |
| Shares | 129.7M | 360.7K | 129.0M | −367.1K (−0.3%) |
| Value | $28.0B | $77.8M | $29.9B | +$2.00B (+7.2%) |
13 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (101)
Institutions that held Biogen Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Showing the largest 100 of 101 by value.
Sold out (96)
Institutions that held Biogen Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (13)
Institutions that held Biogen Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 291,725 | $62.9M |
| Degroof Petercam Asset Management | 29,300 | $6.32M |
| Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | 27,821 | $6.00M |
| Shell Asset Management Co | 4,055 | $940.0K |
| Cognios Beta Neutral Large Cap Fund, LP | 2,052 | $442.5K |
| Connectus Wealth, LLC | 1,814 | $391.2K |
| Eudaimonia Partners, LLC | 1,722 | $371.3K |
| Richelieu Gestion PLC | 858 | $185.0K |
| Norwood Financial Corp | 355 | $76.5K |
| FSA Wealth Management LLC | 344 | $74.2K |
| Cambridge Trust Co | 335 | $72.2K |
| Pflug Koory, LLC | 238 | $51.3K |
| Retirement Group, LLC | 49 | $10.6K |